251 Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IBI362 in Overweight or Obesity Subjects
The studys senior author David Fisher, professor of dermatology at Harvard Medical School, said, of the reports he had read, the coverage was generally accurate and balanced: I have not seen any problems (yet) No particular gaps either
Patients should be monitored for gallbladder symptoms, as rapid weight loss increases the risk of gallstones
If side effects persist, your doctor may recommend alternative treatments or inhaler types
This creates demand for more targeted approaches that control excessive inflammation while preserving the beneficial aspects of the inflammatory response
Medication Format Options Your PCP May Offer PCPs can prescribe GLP-1 medications in injectable and oral formulations